Sildenafil: 25 Years Later
25 years after the FDA approval of sildenafil, Dr. Hirsch, Dr. Rosen, and Dr. Goldstein reflect on the past and future of PDE5 inhibitors.
Read More
John P. Sfakianos
Use of the Cxbladder Monitor Urine Genomics Test for Surveillance of Patients with Non-Muscle-Invasive Bladder Cancer
Daniel Shoskes, MD; John P. Sfakianos, MD; and Sima P. Porten, MD, MPH; discuss the Cxbladder Monitor Test in surveillance of NMIBC patients.
Read More